2019
Human induced pluripotent stem cell-derived extracellular vesicles reduce hepatic stellate cell activation and liver fibrosis
Povero D, Pinatel E, Leszczynska A, Goyal N, Nishio T, Kim J, Kneiber D, de Araujo Horcel L, Eguchi A, Ordonez P, Kisseleva T, Feldstein A. Human induced pluripotent stem cell-derived extracellular vesicles reduce hepatic stellate cell activation and liver fibrosis. JCI Insight 2019, 5 PMID: 31184999, PMCID: PMC6675559, DOI: 10.1172/jci.insight.125652.Peer-Reviewed Original ResearchMeSH KeywordsAnimalsApoptosisCell MovementCell ProliferationChemical and Drug Induced Liver InjuryChemotaxisDisease Models, AnimalExtracellular VesiclesHepatic Stellate CellsHumansInduced Pluripotent Stem CellsLiverLiver CirrhosisMaleMiceMice, Inbred C57BLMicroRNAsTranscriptomeTransforming Growth Factor betaConceptsHepatic stellate cell activationChronic liver diseaseAnti-fibrotic effectsStellate cell activationLiver fibrosisLiver diseaseExtracellular vesiclesInduced pluripotent stem cellsCell activationDuct ligation-induced liver fibrosisFlow cytometryAnti-fibrotic approachesDevelopment of cirrhosisPro-fibrogenic responseProgression of fibrosisStem cell-derived extracellular vesiclesAnti-fibrotic strategiesCharacterization of iPSCsGreatest unmet needCell-derived extracellular vesiclesMiR-92a-3pWound healing responseStem cellsIPSC-EVsLiver injury
2017
A risk prediction score for acute kidney injury in the intensive care unit
Malhotra R, Kashani K, Macedo E, Kim J, Bouchard J, Wynn S, Li G, Ohno-Machado L, Mehta R. A risk prediction score for acute kidney injury in the intensive care unit. Nephrology Dialysis Transplantation 2017, 32: 814-822. PMID: 28402551, DOI: 10.1093/ndt/gfx026.Peer-Reviewed Original ResearchConceptsAcute kidney injuryIntensive care unitAcute risk factorsRisk score modelICU admissionKidney injuryCare unitValidation cohortKidney diseaseRisk factorsTest cohortTreatment of AKIAtherosclerotic coronary vascular diseaseMulticenter prospective cohort studyGlobal Outcomes criteriaChronic kidney diseaseHigh-risk patientsProspective cohort studyChronic liver diseaseCongestive heart failureTime of screeningCoronary vascular diseaseRisk prediction scoreEarly therapeutic interventionExternal validation cohort